European Heart Journal Advance Access published online on September 11, 2008
European Heart Journal, doi:10.1093/eurheartj/ehn399
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org
Erythropoietin, haemoglobin, heart failure, and mortality
Hypertension, Nephrology, Dialysis and Transplantation
Auburn University
Suite 3
2609 Village Professional Drive
Opelika, AL 36801
USA
Tel: +11 334 749 6523
Fax: +11 334 742 0242
Email: hndt512@bellsouth.net
| The first 10% of the full text of this article appears below. |
I would like to congratulate Dr van der Meer and his colleagues for their work on their evaluation of the relationship of haemoglobin, endogenous erythropoietin (EPO) levels and increased mortality in patients with congestive heart failure.1 Since we have been involved in evaluation of EPO levels in patients